A generic and tribal revision of the North American Aleocharinae (Coleoptera, Staphylinidae) / Charles H. Seevers ; with additions and annotations by Lee H. Herman.

v.71(1978)

New North American fleas.

v.29:no.15(1944)

Annual ceremony of the Pawnee medicine men / by Ralph Linton, Assistant Curator of North American Ethnology.

no.8(1923)

The civilization of the Mayas / by J. Eric Thompson, Assistant Curator of Mexican and South American Archaeology.

no.25(1927)

The North American Crinoidea camerata / by Charles Wachsmuth and Frank Springer.

v.20-21 (1897) plates

The solar year of the Mayas at Quirigua, Guatemala / by J. Eric Thompson, Assistant Curator of Central and South American Archaeology; 2 text-figures; Berthold Laufer, Curator, Department of Anthropology, editor.

v.17:no.4(1932)

Use of tobacco among North American Indians / by Ralph Linton, Assistant Curator of North American Ethnology.

no.15(1924)

North American plesiosaurs : by Samuel W. Williston -- ; Oliver C. Farrington --

v.2:no.1(1903)

The solar year of the Mayas at Quirigua, Guatemala / by J. Eric Thompson, Assistant Curator of Central and South American Archaeology; 2 text-figures; Berthold Laufer, Curator, Department of Anthropology, editor.

v.17:no.4(1932)

North American Quaternary Canis / Ronald M. Nowak.

no.6 (1979)

Biology of three species of North American Triatominae (Hemiptera: Reduviidae: Triatominae) fed on rabbits

Aspects related to hatching, lifetime, number of blood meals for molting, mortality, feeding time, and postfeeding defecation delay were evaluated and compared in each instar of three North American Triatominae: Triatoma gerstaeckeri, Triatoma lecticularia and Triatoma protracta, all of them fed on rabbits. No significant differences (p > 0.05) were found among the three species regarding mean hatching rate, which was close to 20 days. Egg-to-adult development times were significantly shorter (p < 0.05) for T. lecticularia. Number of blood meals for molting to next instar ranged from one to five for T. protracta, and from one to six for T. gerstaeckeri and T. lecticularia. Mortality rates were higher in younger nymphs of T. lecticularia and T. protracta, while rates in T. gerstaeckeri were higher in fifth-instar nymphs. Mean feeding time was longest in T. gerstaeckeri, followed by T. lecticularia. More than twice the number of T. gerstaeckeri nymphs completed the development process, if compared to the nymphs from the other two species. Defecation delay was less than 10 min for T. lecticularia, T. protracta and the youngest nymphs of T. gerstaeckeri. Results point out that these three species may be important potential vectors of Trypanosoma cruzi for human populations, in areas of Mexico where these species are currently present.

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.

PURPOSE: Patients with primary cutaneous melanoma > or = 1.5 mm in thickness are at high risk of having regional micrometastases at the time of initial surgical treatment. A phase III international study was designed to evaluate whether prophylactic isolated limb perfusion (ILP) could prevent regional recurrence and influence survival. PATIENTS AND METHODS: A total of 832 assessable patients from 16 centers entered the study; 412 were randomized to wide excision (WE) only and 420 to WE plus ILP with melphalan and mild hyperthermia. Median age was 50 years, 68% of patients were female, 79% of melanomas were located on a lower limb, and 47% had a thickness > or = 3 mm. RESULTS: Median follow-up duration is 6.4 years. There was a trend for a longer disease-free interval (DFI) after ILP. The difference was significant for patients who did not undergo elective lymph node dissection (ELND). The impact of ILP was clearly on the occurrence-as first site of progression - of in-transit metastases (ITM), which were reduced from 6.6% to 3.3%, and of regional lymph node (RLN) metastases, with a reduction from 16.7% to 12.6%. There was no benefit from ILP in terms of time to distant metastasis or survival. Side effects were higher after ILP, but transient in most patients. There were two amputations for limb toxicity after ILP. CONCLUSION: Prophylactic ILP with melphalan cannot be recommended as an adjunct to standard surgery in high-risk primary limb melanoma.